| For: | Pan Q, Xu QY, Zhang LH, He YF. What is the role of nonalcoholic fatty liver disease in pulmonary carcinoma development? World J Gastroenterol 2025; 31(5): 97500 [PMID: 39926215 DOI: 10.3748/wjg.v31.i5.97500] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i5/97500.htm |
| Number | Citing Articles |
| 1 |
Cigdem Elif Celik, Elvin Chalabiyev, Volkan Gurler, Mehmet Ruhi Onur, Taha Koray Şahin, Omer Dizdar, Fusun Ozmen. Assessment of the correlation between visceral adiposity and liver fat in metastatic colorectal cancer patients. International Journal of Colorectal Disease 2025; 40(1) doi: 10.1007/s00384-025-04967-x
|
| 2 |
Nuo Xu, Xianshi Zhou, Dan Yu, Jinming Zhang, Xiaotu Xi, Huiyan Zeng. Global burden of metabolic dysfunction-associated steatotic liver disease attributable to tobacco, 1990–2023, and projected trends to 2038. Journal of Diabetes & Metabolic Disorders 2026; 25(2) doi: 10.1007/s40200-026-01997-2
|
| 3 |
Yih-Dih Cheng, Hong-Yi Chiu, Yu-Jen Chiu, Miau-Rong Lee, Shih-Chang Tsai, Jai-Sing Yang. Transcriptomic Profiling Reveals Inflammatory, Fibrotic, and Apoptotic Signatures in a Methionine–Choline-Deficient Diet-Induced Murine Model of Metabolism-Dysfunction-Associated Steatohepatitis. International Journal of Molecular Sciences 2026; 27(13) doi: 10.3390/ijms27136033
|
| 4 |
Benjamin Blaske, Michael Ward, Ragesh Babu Thandassery. Metabolic dysfunction-associated steatotic liver disease and the consequence of extra-hepatic malignancy. World Journal of Hepatology 2026; 18(8): 124224 doi: 10.4254/wjh.124224
|